Capital Expenditures for Elevance Health (ELV)
According to Elevance Health's latest reported financial statements, the company's current capital expenditures (TTM) is $1.16B USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$1.16B
YoY change
-11.1%
5Y CAGR
+1.8%
Peak year (2023)
$1.30B
Cumulative capital expenditures
$15.78B
CapEx history chart for Elevance Health (ELV) from 2001 to 2025
CapEx history table for Elevance Health (ELV) from 2001 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $1.12B | -11.1% | ||
| 2024 | $1.26B | -3.1% | ||
| 2023 | $1.30B | +12.5% | ||
| 2022 | $1.15B | +6.0% | ||
| 2021 | $1.09B | +6.5% | ||
| 2020 | $1.02B | -5.2% | ||
| 2019 | $1.08B | -10.8% | ||
| 2018 | $1.21B | +52.9% | ||
| 2017 | $790.20M | +35.4% | ||
| 2016 | $583.60M | -3.2% | ||
| 2015 | $602.90M | -3.8% | ||
| 2014 | $626.60M | +3.2% | ||
| 2013 | $607.30M | +11.5% | ||
| 2012 | $544.90M | +4.9% | ||
| 2011 | $519.50M | +15.1% | ||
| 2010 | $451.40M | +19.3% | ||
| 2009 | $378.40M | +9.5% | ||
| 2008 | $345.60M | +7.3% | ||
| 2007 | $322.00M | +66.1% | ||
| 2006 | $193.90M | +19.8% | ||
| 2005 | $161.80M | +18.3% | ||
| 2004 | $136.80M | +23.6% | ||
| 2003 | $110.70M | -10.2% | ||
| 2002 | $123.30M | +75.1% | ||
| 2001 | $70.40M | — |
CapEx values are taken from Elevance Health's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Elevance Health (ELV) capital expenditures totalled $1.12B – declined 11.1% year-over-year.
Over 2020–2025 (5 years), Elevance Health capital expenditures expanded at a +1.8% compound annual rate, with the latest reading among the more recent periods of the dataset.
Elevance Health capital expenditures declined from $1.30B in 2023 to $1.12B in 2025, a 13.9% drawdown.
The dataset's maximum capital expenditures sits at $1.30B (2023); the minimum reading of $70.40M dates to 2001.
Within Healthcare, Elevance Health (ELV) ranks 9th among 8 peers we track. The peer median for capital expenditures is $3.87B.
Elevance Health Capital Expenditures by Year
Elevance Health Capital Expenditures 2025: $1.12B
Elevance Health capital expenditures in 2025 was $1.12B, declined 11.1% below 2024.
Elevance Health Capital Expenditures 2024: $1.26B
Elevance Health capital expenditures in 2024 was $1.26B, edged down 3.1% below 2023.
Elevance Health Capital Expenditures 2023: $1.30B
Elevance Health capital expenditures in 2023 was $1.30B, grew 12.5% from 2022. This figure represents the highest annual value in the available history.
Elevance Health Capital Expenditures 2022: $1.15B
Elevance Health capital expenditures in 2022 was $1.15B, grew 6.0% from 2021.
Elevance Health Capital Expenditures 2021: $1.09B
Elevance Health capital expenditures in 2021 was $1.09B.
See more financial history for Elevance Health (ELV).
Sector peers — CapEx
Companies in the same sector as Elevance Health, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Elevance Health's capital expenditures?
- Latest reported capital expenditures for Elevance Health (ELV) is $1.16B (period ending March 31, 2026).
How has Elevance Health capital expenditures changed year-over-year?
- Elevance Health (ELV) capital expenditures changed -11.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Elevance Health capital expenditures?
- Elevance Health (ELV) capital expenditures compound annual growth rate is +1.8% over the most recent 5 years available.
When did Elevance Health capital expenditures hit its highest annual value?
- Elevance Health capital expenditures reached its highest annual value of $1.30B in 2023.
What was Elevance Health capital expenditures in 2024?
- Elevance Health (ELV) capital expenditures in 2024 was $1.26B.
What was Elevance Health capital expenditures in 2025?
- Elevance Health (ELV) capital expenditures in 2025 was $1.12B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ELV Overview
Company profile, financial tools, and key metrics
ELV Revenue Counter
Earns $6,355 every second. See per minute, hour, and day.
ELV Earnings Counter
Earns $166.25 per second net profit. See per minute, hour, and day.
ELV Economic Scale
Exceeds Ukraine's GDP. Compare with world economies.
ELV What If Invested
What if you had invested $1,000? See historical returns from any date.
ELV How It Makes Money
Discover visual breakdown of $200.41B in revenue — where it comes from and where it goes.
ELV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ELV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ELV Daily Price Character
Steady · 51.8% historical win rate (green days). Streaks & record days.
ELV Buybacks
4.41% TTM buyback yield. Shareholder yield & SBC comparison.
ELV Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
ELV Dividend Profile
Yield: 1.82%. Safety: 7/8. See full history.
ELV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ELV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.